Results of Antihypertensive Treatment Trials in the Elderly

2002 ◽  
Vol 11 (1) ◽  
pp. 41-48 ◽  
Author(s):  
Gastone Leonetti ◽  
Alberto Zanchetti
1993 ◽  
Vol 11 (Supplement 4) ◽  
pp. S29???S36 ◽  
Author(s):  
Jan N. Lessem ◽  
Michael A. Weber

2004 ◽  
Vol 22 (Suppl. 1) ◽  
pp. S149
Author(s):  
Y Kawano ◽  
S Takishita ◽  
H Matsuoka ◽  
T Mannami ◽  
T Omae

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Alberto Mazza ◽  
Emilio Ramazzina ◽  
Stefano Cuppini ◽  
Michela Armigliato ◽  
Laura Schiavon ◽  
...  

Arterial hypertension (HT) is age dependent and, with the prolongation of life expectancy, affects more and more elderly people. In the elderly, HT is a risk factor for organ damage and cardiovascular (CV) events. Both pharmacologic and nonpharmacologic reduction of blood pressure (BP) is associated with a corresponding decrease in systolic-diastolic or isolated systolic HT. Clinical trials have shown that BP lowering is associated with a decrease in stroke and other CV events. Therefore, BP reductionper seappears more important than a particular class of antihypertensive drugs. The benefit of antihypertensive treatment has been confirmed up to the age of 80 years, remaining unclear in the octogenarians. The benefit in lowering diastolic BP between 80 and 90 mmHg is well established, while that of lowering systolic BP below 140 mmHg requires further confirmations.


Sign in / Sign up

Export Citation Format

Share Document